Biomimetic Nanoparticles for Precision Targeting of Cancer Stem Cells and Tumor Recurrence
2026 | NEWPORT INTERNATIONAL JOURNAL OF BIOLOGICAL AND APPLIED SCIENCES (NIJBAS) | Pp. 95-101
Tumor recurrence and therapeutic resistance remain major obstacles in effective cancer management, largely driven by a small but highly resilient subpopulation of cells known as cancer stem cells (CSCs). These cells possess self-renewal capacity, multipotency...